Skin Disease Clinical Trial
Official title:
Determination of the Minimal Dose of Visible Light Required to Achieve Immediate Pigment Darkening, Persistent Pigment Darkening, and Delayed Tanning for Fitzpatrick Skin Types IV-VI Utilizing Two Visible Light Sources.
The purpose of this study is to learn more about the potential effects of visible light on the skin. More specifically, this study will examine whether an incandescent lamp (light bulb) or LED light bulb can cause skin to become darker. Investigators will determine the minimum threshold dose required to achieve immediate pigmentation darkening (IPD), persistent pigmentation darkening (PPD), and delayed tanning (DT) for Fitzpatrick skin types IV - VI utilizing two visible light sources.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT01012453 -
A Randomised Clinical Trial in a Population of Health Care Workers With Hand Eczema
|
N/A | |
Not yet recruiting |
NCT05561595 -
Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma
|
N/A | |
Completed |
NCT00910260 -
Impact on UVB Narrow Band and UVA1 Therapy on Serum 25-hydroxyvitamin D Levels
|
Phase 4 | |
Completed |
NCT02309905 -
Evaluation of Tele-expertise for Inmates With a Dermatological Lesion
|
N/A | |
Completed |
NCT02338076 -
A Study to Document the Effect of Petrolatum on Innate Immune Responses in the Skin
|
N/A | |
Completed |
NCT02465476 -
Rationalization of the Treatment Pathway of Patient Suffering From Rare Skin Disease With Telemedicine
|
N/A | |
Completed |
NCT00001648 -
Structure of the Herpes Simplex Virus Receptor
|
N/A | |
Completed |
NCT01187732 -
Washing Without Water: Cost-effectiveness of a Rapidly Spreading Nursing Intervention in Bedridden Patients'
|
N/A |